Spectral AI, Inc. (MDAI)

Market Cap	73.51M +129.5%
Revenue (ttm)	19.65M -33.6%
Net Income	-7.57M
EPS	-0.29
Shares Out	31.82M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	504,747
Open	2.270
Previous Close	2.250
Day's Range	2.200 - 2.360
52-Week Range	1.130 - 3.210
Beta	1.16
Analysts	Strong Buy
Price Target	3.00 (+29.87%)
Earnings Date	May 12, 2026

About MDAI

Spectral AI, Inc., an artificial intelligence (AI) company, focuses on predictive medical diagnostics in the United States. The company offers DeepView System, which uses proprietary AI algorithms to distinguish between fully damaged, partially damaged, and healthy human tissue characteristics invisible to the naked eye at the initial time point of wound presentation and delivers a binary prediction on the wounds capacity to heal by a specified time point in the future to assist the physician in making a more accurate, timely, and informed deci...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2013
• Employees: 65
• Stock Exchange: NASDAQ
• Ticker Symbol: MDAI
• Website: https://www.spectral-ai.com

Financial Performance

In 2025, Spectral AI's revenue was $19.65 million, a decrease of -33.57% compared to the previous year's $29.58 million. Losses were -$7.57 million, -50.05% less than in 2024.

Analyst Summary

According to one analyst, the rating for MDAI stock is "Strong Buy" and the 12-month stock price target is $3.0.

Price Target

$3.0

(29.87% upside)

Analyst Consensus: Strong Buy